Global DuoTrav® Study
Conditions: Open Angle Glaucoma; Ocular HypertensionInterventions: Drug: Beta-blocker monotherapy; Drug: Travoprost 0.004% / timolol 0.5% fixed combination ophthalmic solutionSponsor: Alcon ResearchActive, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2013 Category: Research Source Type: clinical trials
Effect of SIMBRINZA™ As an Added Therapy to a Prostaglandin Analogue
Conditions: Ocular Hypertension; Open Angle GlaucomaInterventions: Drug: Brinzolamide 1%/brimonidine 0.2% ophthalmic suspension; Drug: Vehicle; Drug: Prostaglandin analogue ( TRAVATAN Z® , LUMIGAN®, XALATAN®)Sponsors: Alcon Research; Alcon ResearchNot yet recruiting - verified September 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 4, 2013 Category: Research Source Type: clinical trials
An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
Conditions: Glaucoma; Ocular HypertensionInterventions: Drug: bimatoprost 0.01%; Drug: travatan 0.004%; Drug: timolol 0.5%; Drug: hypromellose 0.3%Sponsor: AllerganCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 17, 2013 Category: Research Source Type: clinical trials
Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients
Conditions: Pediatric Glaucoma; Elevated IOP in Pediatric Patients; Ocular Hypertension in Pediatric PatientsInterventions: Drug: Travoprost 0.004% PQ ophthalmic solution; Drug: Timolol, 0.5% or 0.25% ophthalmic solution; Drug: Travoprost VehicleSponsor: Alcon ResearchCompleted - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2012 Category: Research Source Type: clinical trials
Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy
Condition: GlaucomaIntervention: Drug: Travoprost/Timolol Maleate BAK-Free Fixed CombinationSponsor: Alcon ResearchTerminated - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2012 Category: Research Source Type: clinical trials
Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost
Condition: Open-angle GlaucomaInterventions: Device: iStent; Drug: TravoprostSponsor: Glaukos CorporationActive, not recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2011 Category: Research Source Type: clinical trials
A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension
Conditions: Open-angle Glaucoma; Ocular HypertensionInterventions: Drug: Travoprost 0.004%/timolol 0.5% ophthalmic solution; Drug: Travoprost ophthalmic solution, 0.004%; Drug: Timolol maleate ophthalmic solution, 0.5%Sponsor: Alcon ResearchCompleted - verified May 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2007 Category: Research Source Type: clinical trials
